Research & Development

Etcelera Combines Bio-Platforms to Solve Drug Failure Rates
Research & Development Etcelera Combines Bio-Platforms to Solve Drug Failure Rates

If clinical trials become validations of predictions rather than high-risk gambles, the type of capital available for early-stage research will likely undergo a significant shift. For decades, the pharmaceutical industry has operated under a cloud of uncertainty, where nearly half of all drug

Texas A&M Launches $4 Million Study to Combat Screwworm Threat
Research & Development Texas A&M Launches $4 Million Study to Combat Screwworm Threat

By analyzing the genetic relatedness of different fly populations, epidemiologists can determine whether new infestations are local developments or the result of international transport. Texas A&M University has recently initiated a massive $4 million genetic research project to address the

Can Citrus Peel Nanoparticles Kill Cervical Cancer Cells?
Research & Development Can Citrus Peel Nanoparticles Kill Cervical Cancer Cells?

Experimental data shows that these citrus-derived nanoparticles exhibit pH-responsive release, discharging eighty percent of their payload in acidic environments similar to tumor microenvironments. This precision delivery mechanism represents a significant leap forward in addressing the persistent

Are Piezoelectric Nanozymes the Future of Cancer Therapy?
Research & Development Are Piezoelectric Nanozymes the Future of Cancer Therapy?

Current clinical advancements in nanomedicine prioritize the development of materials that can unmask tumor antigens to the immune system through precise cell lysis. This strategic shift reflects a broader recognition that conventional treatments like chemotherapy often falter because they cannot

Could Nomelcitinib Transform Plaque Psoriasis Care?
Research & Development Could Nomelcitinib Transform Plaque Psoriasis Care?

With more than 80 percent of trial participants achieving clear or almost clear skin, nomelcitinib is positioning itself as a robust competitor in the psoriasis treatment landscape. The quest for a highly effective, oral, and safe treatment for autoimmune skin conditions has long been the primary

Can CAR T-Cell Therapy Cure Hairy Cell Leukemia?
Research & Development Can CAR T-Cell Therapy Cure Hairy Cell Leukemia?

Standard retreatment for relapsed hairy cell leukemia often involves cumulative chemotherapy toxicity, prompting the search for alternative therapies that do not carry the risk of graft-versus-host disease. Recent advancements in hematologic oncology have ushered in a new era of precision medicine,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later